Comparison of tepoxalin, carprofen, and meloxicam for reducing intraocular inflammation in dogs
Authors:
- Terry W. LehenbauerTLTerry W. Lehenbauer
- 1 July 2009
- journal article
- research article
- Published by American Veterinary Medical Association (AVMA) in American Journal of Veterinary Research
- Vol. 70 (7) , 902-907
Abstract
Objective—To compare effects of orally administered tepoxalin, carprofen, and meloxicam for controlling aqueocentesis-induced anterior uveitis in dogs, as determined by measurement of aqueous prostaglandin E2 (PGE2) concentrations. Animals—38 mixed-breed dogs. Procedures—Dogs were allotted to a control group and 3 treatment groups. Dogs in the control group received no medication. Dogs in each of the treatment groups received an NSAID (tepoxalin, 10 mg/kg, PO, q 24 h; carprofen, 2.2 mg/kg, PO, q 12 h; or meloxicam, 0.2 mg/kg, PO, q 24 h) on days 0 and 1. On day 1, dogs were anesthetized and an initial aqueocentesis was performed on both eyes; 1 hour later, a second aqueocentesis was performed. Aqueous samples were frozen at −80°C until assayed for PGE2 concentrations via an enzyme immunoassay kit. Results—Significant differences between aqueous PGE2 concentrations in the first and second samples from the control group indicated that aqueocentesis induced uveitis. Median change in PGE2 concentrations for the tepoxalin group (10 dogs [16 eyes]) was significantly lower than the median change for the control group (8 dogs [16 eyes]), carprofen group (9 dogs [16 eyes]), or meloxicam group (9 dogs [16 eyes]). Median changes in PGE2 concentrations for dogs treated with meloxicam or carprofen were lower but not significantly different from changes for control dogs. Conclusions and Clinical Relevance—Tepoxalin was more effective than carprofen or meloxicam for controlling the production of PGE2 in dogs with experimentally induced uveitis. Tepoxalin may be an appropriate choice when treating dogs with anterior uveitis.Keywords
This publication has 20 references indexed in Scilit:
- Effects of an ophthalmic formulation of meloxicam on COX-2 expression, PGE2 release, and cytokine expression in a model of acute ocular inflammationBritish Journal of Ophthalmology, 2007
- Effects of Topical Corticosteroids and Nonsteroidal Anti-Inflammatory Drugs on Prostaglandin E2-Induced Aqueous Flare Elevation in Pigmented RabbitsOphthalmic Research, 2003
- Role of nonsteroidal anti-inflammatory drugs in gastrointestinal tract injury and repairJournal of the American Veterinary Medical Association, 2003
- Laser flaremetric evaluation of experimentally induced blood-aqueous barrier disruption in catsAmerican Journal of Veterinary Research, 2002
- Blood-aqueous barrier in prostaglandin EP2 receptor knockout miceOcular Immunology and Inflammation, 2002
- Constitutive Expression and Localization of COX-1 and COX-2 in Rabbit Iris and Ciliary BodyExperimental Eye Research, 2001
- Carprofen inhibition of flare in the dog measured by laser flare photometryVeterinary Ophthalmology, 1998
- Leukotrienes and Sensory Innervation in Blood-Aqueous Barrier Disruption in the DogJournal of Ocular Pharmacology and Therapeutics, 1992
- Effect of Flunixin Meglumine on the Breakdown of the Blood-Aqueous Barrier Following Paracentesis in the Canine EyeJournal of Ocular Pharmacology and Therapeutics, 1986
- Disruption of the blood-aqueous barrier following paracentesis in the rabbitExperimental Eye Research, 1975